This inventor holds 5 USPTO granted patents. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Yeda Research and Develpment & Co. Ltd. Active years: 2009-2012.
Location History:
- Rishon le Zion, IL (2009 - 2011)
- Beit-Hashmonai, IL (2011 - 2012)
Company Filing History:
5 out of 911 
1 out of 60 
1 out of 1,168 Years Active: 2009-2012
Title: Lora Melnik: Innovator in Inflammatory Disease Research
Introduction
Lora Melnik is a prominent inventor based in Beit-Hashmonai, Israel. She has made significant contributions to the field of biomedical research, particularly in the diagnosis and treatment of inflammatory diseases. With a total of five patents to her name, her work has the potential to impact many lives.
Latest Patents
Lora Melnik's latest patents include innovative developments such as CD44 polypeptides and polynucleotides encoding the same. These inventions focus on antibodies directed against CD44 polypeptides and methods for using them in diagnosing and treating inflammatory diseases. Another notable patent involves isolated polynucleotides encoding novel galectin-8 variant polypeptides, which are crucial for diagnosing, prognosing, and treating rheumatoid arthritis and other chronic inflammatory diseases.
Career Highlights
Throughout her career, Lora has worked with esteemed organizations such as Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the Medical Research Fund of Tel Aviv Sourasky Medical Center. Her work in these institutions has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Lora Melnik has collaborated with notable colleagues, including Itshak Golan and David Naor. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in her field